Development of an Overdose Model doi.org/10.1038/s41598-023-35694-4 Press Release Link to Publication This research provides an accurate way to model overdose in the lab, using human brain cells programmed to respond to many different opioids. Amid an … Read More
Development of a Malaria-on-a-Chip Model doi.org/10.1038/s41598-023-35694-4 Model developed to study Malaria and potential therapeutics Press Release Link to Publication Hesperos scientists have published a groundbreaking study in Scientific Reports, a Nature journal. The publication, titled “Development … Read More
The FDA Modernization Act 2.0 was signed into law eliminating the animal testing mandate in drug discovery.
Read the Open Letter here We are proud to support this open letter to congress encouraging representatives to pass the FDA Modernization Act. Originally passed in 1938, the Federal Food, Drug, and Cosmetics Act (FFDCA) was … Read More
Hesperos, Inc. appoints new Chief Executive Officer, Dr. James Kronauge I’m excited to join Hesperos as we expand the capabilities of the Human-on-Chip platform enabling drug developers unprecedented insight into specific disease states, especially for rare … Read More
1) Validates use of Human-on-a-Chip system to mimic disease mechanisms of rare autoimmune neuropathies that cannot be replicated in animal models.
2) Efficacy data from microphysiological system supported the authorization of a clinical study (NCT04658472) in 2021 through collaboration with Sanofi.
Hesperos, Inc is proud to announce Dr. Virginia Smith’s recent publication in Frontiers in Cell and Developmental Biology which validates the Human-on-a-Chip method to model the rare autoimmune disease, Myasthenia Gravis. Read the full press release below: … Read More